Thu, Jul 04, 2024
The expanded facility was inaugurated in a ceremony officiated by the Minister of Industries Tamil Nadu, T.R.B. Rajaa, British Deputy High Commissioner to India Christina Scott CMG, AstraZeneca Vice President for Asia Area Sylvia Varela and others.
More >
Mon, May 27, 2024
The drugmaker has also announced its financial results for the fourth quarter ended on March 31, 2024, along with a dividend announcement.
Wed, May 08, 2024
AstraZeneca withdraws COVID-19 vaccine: The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect
Wed, May 01, 2024
Covishield news: Covishield, developed by the Pune-based Serum Institute, has been delivered in 175 crore doses. Understandably, this raises concerns about the safety of the shot we all received. This was the most extensively used COVID-19 vaccination in the country.
Tue, Apr 30, 2024
The Oxford-AstraZeneca Covid vaccine, sold as Covishield in India and Vaxzevria in Europe is a viral vector vaccine developed using the modified chimpanzee adenovirus ChAdOx1.
Tue, Mar 19, 2024
AstraZeneca will also pay a non-transferable contingent value right of $3 per share, taking the combined transaction value to about $2.4 billion.
Wed, Jan 31, 2024
The stock was trading higher by 6.44 per cent, or Rs 408.20, at Rs 6749.95 at 9:43 am on Wednesday.
Mon, Jul 24, 2023
AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets.
Tue, May 30, 2023
AstraZeneca Pharma dividend: AstraZeneca Pharma India's board on Tuesday announced a dividend of Rs 16 per equity share for the financial year 2022-23.
Thu, Dec 22, 2022
Sputnik vaccine is ready for production and export. Wockhardt got approval from CDSCO to export 10 crore dose. Income up to ₹ 2000 crore is possible from vaccine export. Wockhardt tied up with SII for vaccine production in UK plant. The agreement with AstraZeneca is expected to extend for a few years. Why Wockhardt is in focus, know full details from Kushal Gupta.
Fri, Aug 19, 2022
Breast cancer is one of the most diagnosed cancer worldwide with an estimated 23 lakh patients diagnosed per year.
Fri, Dec 31, 2021
Serum Institute Of India has applied to the country`s drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the company`s chief executive said on Friday.
Thu, Dec 23, 2021
A three-dose course of AstraZeneca`s COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
Wed, Dec 08, 2021
Serum Institute of India (SII), the world`s biggest vaccine maker, will halve the output of the AstraZeneca COVID-19 shot from next week as it had no fresh orders from the government, its CEO Adar Poonawalla told CNBC-TV18 on Tuesday.
Sat, May 01, 2021
The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.
Sat, Jan 02, 2021
India on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, a government minister confirmed on Saturday.
Wed, Dec 23, 2020
India is likely to approve Oxford/AstraZeneca's coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday
Tue, Nov 24, 2020
AstraZeneca vaccine will be able to vaccinate only 50% of the population by the end 2022, even if there are no supply/ funding constraints, according to Jefferies. A 70% efficacy with AstraZeneca would further delay the time to bring the Pandemic under control in India. High unmet demand leaves potential for other vaccine plays in India. Remdesivir could also see extended sales for Cipla and Cadila Healthcare.
US business activity in November expanded at its fastest rate in more than five years, pointing to a recovery from the pandemic's economic damage. The upbeat data came after Britain's AstraZeneca said its vaccine could be around 90 % effective without any serious side effects.
Mon, Oct 26, 2020
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc said on Monday
Sat, Oct 10, 2020
The agreement, under the Trump administration`s Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19, especially in high-risk population, like those over 80 years old, the US Department of Health and Human Services said.
Capital markets regulator Sebi on Friday slapped a penalty totalling Rs 1.62 crore on nine entities for indulging in fraudulent trading in the scrip of Sterling Green Woods Ltd
Fri, Apr 22, 2016
The company said the launch of the product is based on the settlement terms/litigation outcome with AstraZeneca.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
